CLASS II Device recall · Reported 18 Mar 2020 · FDA Enforcement Report

RayStation/RayPlan 8A, Build Number 0.0.61, stand-alone recalled

Raysearch Laboratories Ab is recalling RayStation/RayPlan 8A, Build Number 0.0.61, stand-alone, distributed in Tennessee. The recall was initiated on 20 Feb 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI 07350002010112
Quantity recalled1 system

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1462-2020
FDA event ID
85065
Recalling firm
Raysearch Laboratories Ab, Stockholm
Classification
Class II
Status
Terminated
Recall initiated
20 Feb 2020
FDA classified
10 Mar 2020
Reported
18 Mar 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

20 Feb 2020Recall initiated by company
10 Mar 2020Classified by FDA+19 days
18 Mar 2020Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for erroneous propagation of the current tabletop positions when applying pitch or roll correction. Even though pitch and roll correction is never propagated, non-zero pitch or roll causes the lateral, longitudinal and vertical values propagated to be incorrect.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RayStation/RayPlan 8A, Build Number 8.0.0.61, stand-alone software treatment planning system

Where it was distributed

The products were distributed to the following US states: TN

Tennessee

Questions about this recall

Is RayStation/RayPlan 8A, Build Number 0.0.61, stand-alone recalled?

Yes. Raysearch Laboratories Ab recalled RayStation/RayPlan 8A, Build Number 0.0.61, stand-alone on 20 Feb 2020. The recall is Class II and its status is Terminated. Recall number Z-1462-2020.

Why was it recalled?

There is a potential for erroneous propagation of the current tabletop positions when applying pitch or roll correction. Even though pitch and roll correction is never propagated, non-zero pitch or roll causes the lateral, longitudinal and vertical values propagated to be incorrect.

Which lots are affected?

UDI 07350002010112

Where was it sold?

The products were distributed to the following US states: TN

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories Ab

All 115

Other Medical Software recalls

All 903